The Salk team expanded upon their previous development of a drug candidate J147, which takes a different tack by targeting Alzheimer’s major risk factor—old age. In the new work, the team showed that the drug candidate worked well in a mouse model of aging not typically used in Alzheimer’s research. When these mice were treated with J147, they had better memory and cognition, healthier blood vessels in the brain and other improved physiological features.
“Initially, the impetus was to test this drug in a novel animal model that was more similar to 99% of Alzheimer’s cases,” says Prof Antonio Currais. “We did not predict we’d see this sort of anti-aging effect, but J147 made old mice look like they were young, based upon a number of physiological parameters.”
Alzheimer’s is the 3rd ...
Read More
Recent Comments